Market Overview

Northwest Biotherapeutics Offers Update on Phase 3 Trial of DCVax-L: says Trial Enrolled 331 Patients, Data Events Accumulating Towards Trial Ednpoints

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News FDA

 

Related Articles (NWBO)